Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis.

Saved in:
Bibliographic Details
Title: Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis.
Authors: Burghart L; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria., Treiber S; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Bauer D; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria., Halilbasic E; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Rare Liver Diseases (RALID) Centre of the ERN RARE-LIVER, At the Vienna General Hospital, Vienna, Austria., Hofer BS; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Laboratory, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Christian Doppler Lab for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria., Mandorfer M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Rare Liver Diseases (RALID) Centre of the ERN RARE-LIVER, At the Vienna General Hospital, Vienna, Austria.; Vienna Hepatic Hemodynamic Laboratory, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Gschwantler M; Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria.; Sigmund Freud University, Vienna, Austria., Schwarz C; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria., Trauner M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Rare Liver Diseases (RALID) Centre of the ERN RARE-LIVER, At the Vienna General Hospital, Vienna, Austria., Reiberger T; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Rare Liver Diseases (RALID) Centre of the ERN RARE-LIVER, At the Vienna General Hospital, Vienna, Austria.; Vienna Hepatic Hemodynamic Laboratory, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Christian Doppler Lab for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria., Stättermayer AF; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Rare Liver Diseases (RALID) Centre of the ERN RARE-LIVER, At the Vienna General Hospital, Vienna, Austria.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Jan; Vol. 63 (2), pp. 264-275. Date of Electronic Publication: 2025 Aug 28.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2036
DOI:10.1111/apt.70349